These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Zanamivir: new therapeutic option for influenza]. Caballero E; Prieto C; Ruiz M; Azanza JR Rev Med Univ Navarra; 2000; 44(1):56-61. PubMed ID: 11002900 [No Abstract] [Full Text] [Related]
4. Zanamivir: from drug design to the clinic. Elliott M Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388 [TBL] [Abstract][Full Text] [Related]
7. Treating influenza with zanamivir. Management of Influenza in the Southern Hemisphere Trialists. Silagy CA Lancet; 1999 Feb; 353(9153):669. PubMed ID: 10030350 [No Abstract] [Full Text] [Related]
8. Position statement: global neuraminidase inhibitor susceptibility network. Zambon M; Hayden FG; Antiviral Res; 2001 Mar; 49(3):147-56. PubMed ID: 11428241 [No Abstract] [Full Text] [Related]
9. Zanamivir (Relenza )--a new treatment for influenza. MacConnachie AM Intensive Crit Care Nurs; 1999 Dec; 15(6):369-70. PubMed ID: 11868584 [TBL] [Abstract][Full Text] [Related]
10. [Influenza: from vaccine prevention to antiviral therapy]. Nkoghe D; Scheen AJ Rev Med Liege; 2000 Jan; 55(1):19-23. PubMed ID: 10803033 [TBL] [Abstract][Full Text] [Related]
11. The relentless flu drug. Environ Health Perspect; 1998 Aug; 106(8):A372-3. PubMed ID: 9867459 [No Abstract] [Full Text] [Related]
12. Zanamivir. No noticeable progress against influenza. Can Fam Physician; 2000 Oct; 46():2003-8, 2012-8. PubMed ID: 11184246 [TBL] [Abstract][Full Text] [Related]
13. Two neuraminidase inhibitors for treatment of influenza. Med Lett Drugs Ther; 1999 Oct; 41(1063):91-3. PubMed ID: 10535051 [No Abstract] [Full Text] [Related]
14. Zanamivir: a review of clinical safety. Freund B; Gravenstein S; Elliott M; Miller I Drug Saf; 1999 Oct; 21(4):267-81. PubMed ID: 10514019 [TBL] [Abstract][Full Text] [Related]
15. Implications of the Relenza ruling. Anderson SR J R Soc Med; 2000 Feb; 93(2):55. PubMed ID: 10740568 [No Abstract] [Full Text] [Related]
16. [Drug regulatory agency comments on the editorial about the new influenza drugs]. Tokola O; Pasanen M Duodecim; 2000; 116(6):626-7. PubMed ID: 11787114 [No Abstract] [Full Text] [Related]
17. NICE advises against prescribing zanamivir until further evidence emerges. Commun Dis Rep CDR Wkly; 1999 Oct; 9(42):371. PubMed ID: 10582390 [No Abstract] [Full Text] [Related]
18. Neuraminidase inhibitors for influenza. Moscona A N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481 [No Abstract] [Full Text] [Related]
20. Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. Burls A; Clark W; Stewart T; Preston C; Bryan S; Jefferson T; Fry-Smith A Health Technol Assess; 2002; 6(9):1-87. PubMed ID: 12065066 [No Abstract] [Full Text] [Related] [Next] [New Search]